Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

BACKGROUND: Long-acting injectable (LAI) antipsychotics, compared with oral antipsychotics (OA), have been found to significantly improve patient outcomes, including reduced hospitalizations and emergency room (ER) admissions and increased medication adherence among adult patients with schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dee, Thompson-Leduc, Philippe, Ghelerter, Isabelle, Nguyen, Ha, Lafeuille, Marie-Hélène, Benson, Carmela, Mavros, Panagiotis, Lefebvre, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144083/
https://www.ncbi.nlm.nih.gov/pubmed/33909272
http://dx.doi.org/10.1007/s40263-021-00815-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144083/
https://www.ncbi.nlm.nih.gov/pubmed/33909272
http://dx.doi.org/10.1007/s40263-021-00815-y

Ejemplares similares